Previous studies confirmed that the aqueous crude extract of the leaves of this plant and fractions isolated from these extracts have hypoglycemic and antihyperglycemic effects. Whether the active components are also present in the ethanol extract and its fractions, however, have not yet been investigated. The aim of this study was to evaluate the effects of M. stenopetala leaves ethanol crude extracts and its fractions in healthy and alloxan induced diabetic mice. For single dose hypoglycemic test, normoglycemic mice were given 300 mg/kg of ethanol extract, aqueous extract, petroleum fraction, chloroform fraction, butanol fraction, aqueous residue, glibenclamide (0.66 mg/kg) and distilled water (10 ml/kg) intraperitoneally (i.p). Similarly, for single dose anti-hyperglycemic study, alloxan induced diabetic mice were given the same dose of test substances. For the repeated dose anti-hyperglycemic investigation, diabetic mice were given 300 mg/kg of ethanol extract, aqueous extract, chloroform fraction, butanol fraction, glibenclamide (0.66 mg/kg)) and distilled water (10 ml/kg) through i.p route. The results of single dose hypoglycemic and antihyperglycemic studies indicated that extracts, chloroform fraction, butanol fraction and aqueous residue reduced blood glucose level significantly within the treatment period. The repeated dose of both extracts as well as chloroform and butanol fractions also reduced blood sugar level of diabetic mice significantly. The present findings, therefore, hints that the ethanol extract as well as its chloroform and butanol fractions might also have active principles responsible for antidiabetic effect which confirms the claim for the traditional antidiabetic use of M. stenopetala.
INTRODUCTION
Moringa stenopetala (Baker f.) Cufodontis belongs to the family Moringaceae that is represented only by a single gene Moringa. The genus is represented by 14 species to which M. Stenopetala (Baker f.) Cufodontis belongs. It is a branched tree that grows 6 to 10 m tall, thick at base *Corresponding author. E-mail: nant07@ yahoo.com. Fax: 251 46 2208755. bark with white to pale gray or silvery coloration (Abuye et al., 2003) .
It grows abundantly in Southwestern Ethiopia where the leaves are eaten as vegetable. The species is known by different vernacular names such as "Shiferaw" in Amharic, "Aleko" in Wollaytegna and Gamugna and "Cabbage tree" in English. It grows widely at an altitude range of 1000 to 1800 m. M. stenopetala (Baker f.) Cufodontis is a multipurpose plant. The leaves are one of the best vegetable foods that can be found in the locality (Abuye et al., 2003) . The flowers are good nectar sources for honey; the seeds are used in clearing muddy water; the wet or dried root part chopped and mixed with water is also used to treat malaria (Mekonnen and Gesssesse, 1998) .
It has been reported that M. stenopetala (Baker f.) Cufodontis has medicinal value for stomach pain and to expel retained placenta following birth (Mekonnnen, 1999) , antileshimanial activity (Mekonnen and Gessesse, 1998) , antitrypanosomial activity and antimicrobial activities (Biffa, 2005) . Study made on the crude aqueous extract of the leaves of M. stenopetala (Baker f.) Cufodontis on rabbit (Makonnen et al., 1997) and mice (Mussa et al., 2008) indicated the hypoglycemic activity of the plant. Moreover, the fractions isolated from the aqueous extract of the plants were also shown to have both hypoglycemic and antihyperglycemic effects (Mussa et al., 2008) . The antidiabetic effects of the ethanol extract and its fractions, however, were not investigated. The aim of this study was, therefore, to evaluate the hypoglycemic and antihyperglycemic activity of ethanol extract of M. stenopetala leaves as well as its chloroform, butanol and petroleum fractions.
MATERIALS AND METHODS

Plant material collection
Leaves of M. stenopetala (Baker f.) Cufodontis were collected from Arbaminch town, 502 km away from Addis Ababa, in the Garden of Arbaminch Health Science College on 07 July, 2008. The plant material was authenticated by the National Herbarium, Department of Biology, Addis Ababa University, where a voucher number 001 was given and specimen of M. stenopetala (Baker f.) Cufodontis was deposited.
Aqueous extract preparation
The powdered leaves of M. stenopetala (50 g) was soaked with warm distilled water and agitated for one day using a shaker. Then, the macerate was filtered with muslin cloth four times and was lyophilized. The aqueous extract yielded 27.86 % (13.93 g) and was stored in refrigerator for subsequent experiments (Salawu et al., 2009 ).
Ethanol extract preparation
Air dried powdered leaves of M. stenopetala (400 g) were soaked with 70% (v/v) ethanol for three days, successively. This was done three times, and was filtered with Whatman No. 1 filter paper and the filtrates were then mixed. The combined filtrates were concentrated using Rota Vapor (Büchi Rota Vapor vac R-500, Switzerland). The aqueous residues were dried in a steam bath at 40°C and kept in desiccators for future use. The eth anol extract yielded 20.42% (81.66 g) and was stored in refrigerator for subsequent experiments (Babu et al., 2003) .
Solvent-solvent separation from the ethanol extract
Ten grams of the ethanol extract of the leaves of the plant was Nardos et al. 2221 dissolved in 100 ml of warm distilled water, and solvent-solvent separation was done according to Samsam-Sharjat (1992) method. The dissolved ethanol extract was separated in a separatory funnel with petroleum ether (40 to 60°C), chloroform and n-buta nol, successively until extracting solvents became colorless. In all cases of separation, 150 ml of the solvents were used. After completing the separation process, the solvents were recovered by Rota Vapor. The separates and the aqueous residue were dried by steam bath at 40°C, and were kept in the refrigerator t ill when they would be used.
Animal preparations
Swiss albino mice (20 to 30 g) of both sexes were used for pharmacologic evaluations. The animals were obtained from the Animal House, Department of Pharmacology, Faculty of Medicine, Addis Ababa University. The institutional review board or ethical committee of the faculty approved the use of animals adhering declaration of Helsinki. All the animals used for this study were kept and maintained under laboratory conditions of temperature (22 ± 3°C), humidity and 12 h day-12 h light. They were expo sed to free access of food (standard pellet diet) and water ad libitum. Prior to experimentation, the animals were acclimatized to the test environment for an hour (Ojewole et al., 2007) .
Induction of diabetes in mice
After 16 h fasting, diabetes was induced to the mice by a single intraperitoneal (i.p.) injection of 120 mg/kg alloxan monohydrate dissolved in distilled water. Seven days after alloxan injection, diabetic mice were screened and used for the experiment (Frode and Medeiros, 2008) .
Screening for hypoglycemic effect
Healthy 16 h fasted mice were divided into eight groups of five mice each. Extracts and control substances were administered by intraperitoneal injection to all groups. Groups 1 to 6 were given 300 mg/kg of 70% ethanol extract, aqueous extract, petroleum ether fraction, chloroform fraction, butanol fraction and aqueous residue. Groups 7 and 8 served as positive and negative control and they received glibenclamide (0.66 mg/kg) and distilled water (10 ml/kg), respectively. In order to choose the optimum dose causing hypoglycemia, different doses of aqueous ethanol extract (200, 300 and 500 mg/kg body weight) was tested as a pilot study and better effect was observed at 300 mg/kg.
Screening for antihyperglycemic effect
Diabetes was induced in mice with a single intraperitoneal injection of 120 mg/kg alloxan monohydrate dissolved in distilled water after overnight fasting. Seven days after the alloxan injection, diabetic mice were screened and divided into eight groups of five mice each. Same procedure was then used to administer the test substances as well as the standard and the vehicle. Alloxan induced diabetic mice fasted for 16 h, and were selected and divided into six groups of six mice each for the repeated dose testing. Groups 1 to 4 were administered with 300 mg/kg of 70% ethanol crude extract, aqueous crude extract, chloroform fraction and butanol fractio,n respectively, daily for 8 days through i.p route. Groups 5 and 6 served as control and received glibenclamide (0.66 mg/kg) and distilled water (10 ml/kg) daily for 8 days through intraperitoneal route, respectively. 71.2 ± 2.9*** 59.4 ± 3.2*** 53 ± 4.2*** 49.6 ± 4.9*** VIII Control 90.8 ± 2.5 90.6 ± 1.8 88 ± 5.6 86 ± 3.8 87.6 ± 7.1 *, P < 0.05, **, P < 0.01 and ***, P < 0.001 as compared to the control. Results are means ± S.E.M. of n = 5. Dose of extracts and fractions = 300 mg/kg; Dose of glibenclamide = 0.66 mg/kg; Distilled water = 10 ml/kg.
Blood glucose level determination
For acute hypoglycemic and antihyperglycemic tests, blood samples were obtained from the tail vein of normoglycemic and alloxan induced diabetic mice, respectively, and glucose levels were determined at the beginning of the experiment (0 min), as well as at 60, 120, 180 and 240 min after administration using Hemocue Glucose 201 + Microcuvatess and Hemocue Glucose 201 + analyzer.
Acute toxicity and behavioral pattern studies
Healthy adult albino mice of either sexes that fasted for 16 h were divided into six groups (n = 6) and were administered the ethanol extract at the doses of 10, 15, 20, 30 and 50 g/kg of body weight and water for the control group orally. The animals were then observed continuously for 2 h for the following profiles:
1. Behavioral profile: alertness, restlessness, irritability and fearfulness. 2. Neurological profile: spontaneous activities, reactivity, touch response, pain response and gait. 3. Autonomic profile: defecation and urination.
After a period of 24 and 72 h, they were observed for any lethality (Shirwaikar et al., 2006) .
Statistical analysis
Values were expressed as means ± S.E.M. Statistical differences between the treatments and the controls were tested by one-way analysis of variance (ANOVA), followed by Tukey/Kramer multiple comparison tests using the "Graph Pad Instat" statistic computer program. A difference in the mean values of P < 0.05 was considered to be statistically significant.
RESULTS
Effect of single doses of the test substances in normoglycemic mice
Administration of single doses of different extracts and fractions of M. stenopetala was found to reduce blood glucose level in normoglycemic mice. The ethanol extract significantly lowered blood glucose level as compared to the control at 60, 180 and 240 min (P < 0.01) and 120 min (P < 0.001). Both aqueous and chloroform extracts resulted in similar reduction of blood glucose level at 120 min (P < 0.01), 180 min (P < 0.05) and 240 min (P < 0.05) after administration as compared to the control. Butanol fraction also showed significant reduction (P < 0.05) similar to both aqueous crude extract and chloroform fraction starting from 180 min after administration of the test substance. Petroleum and aqueous residue fractions, however, did not show any significant reduction of plasma glucose level within 4 h of treatment (Table 1 ). The reduction in blood glucose level with all test substances was observed to be more than that with the standard at the doses employed as shown in Table 1 .
Effect of single doses of the test substances in alloxan induced diabetic mice
In alloxan induced diabetic mice, single dose of ethanol extract resulted in significant reduction of blood glucose level at 60 min (P < 0.05), as well as 120, 180 and 240 min (P < 0.001) after administration of the test substance. Aqueous extract also showed significant reduction in blood glucose level at 120 min (P < 0.01) as well as at 180 and 240 min (P < 0.001). The aqueous residue and chloroform and butanol fractions showed similar pattern of reduction in blood glucose level as that of the ethanol extract as shown in Table 2 . The reduction in blood glucose level with all test substances was observed to be more than that with the standard at the doses employed as shown in Table 2 .
Effect of repeated doses of the test substances in alloxan induced diabetic mice
As shown in Table 3 , repeated intraperitoneal administration of the ethanol extract resulted in significant reduction .4 ± 5.3*** 100.6 ± 2.4*** 85.6 ± 5.4*** II Aqueous extract 146.4 ± 2.9 133.8 ± 2.8 115 ± 3.9** 94 ± 3.1*** 89 ± 3.5*** III Petroleum fraction 152 ± 2.8 150.6 ± 4.9 153.4 ± 4.4 138.8 ± 4.6 134.6 ± 2.0 IV Chloroform fraction 141.8 ± 4.8 127.8 ± 4.0* 108.6 ± 5.6*** 90.4 ± 7.2*** 80.6 ± 5.6*** V Butanol fraction 146.6 ± 6.7 129 ± 4.8* 109 ± 2.2*** 79.2 ± 3.7*** 84.6 ± 3.0*** VI Aqueous Residue 134 ± 4.6 128.4 ± 3.2* 122.6 ± 3.1* 123.8 ± 2.6* 121 ± 1.8* VII Standard 146.6 ± 4.7 123.6 ± 3.4** 82 ± 6.7*** 63.8 ± 3.7*** 61.6 ± 2.5*** VIII Distilled water 147 ± 2.8 146.6 ± 2.5 146 ± 2.6 148.2 ± 6.6 139.8 ± 2.8 *P < 0.05, **P < 0.01, ***P < 0.001 as compared to the control. Results are means ± S.E.M. of n = 5. Dose of extracts and fractions = 300 mg/kg; Dose of glibenclamide = 0.66 mg/kg; Distilled water = 10 ml/kg. 155.8 ± 2.9 145.5 ± 2.4** 119.8 ± 1.7*** IV Butanol fraction 170 ± 2.2 158.5 ± 2.6 147.2 ± 2.6** 121.7 ± 3.2*** V Standard 165.8 ± 5.7 124.3 ± 3.2*** 112.2 ± 4.1*** 103.7 ± 2.1*** VI Diabetic control 164.8 ± 5.0 167 ± 1.8 162.5 ± 3.8 167.7 ± 1.5 *P < 0.05, **P < 0.01, ***P < 0.001 as compared to the control. Results are means ± S.E.M. of n = 5. Dose of extracts and fractions = 300 mg/kg; Dose of glibenclamide = 0.66 mg/kg; Distilled water = 10 ml/kg.
in blood glucose level (P < 0.001) starting from the 3rd day after administration. The aqueous extract resulted in significant reduction of blood glucose level on the 3rd day (P < 0.01) and on the 5 and 8th days (P < 0.001) after administration. For both chloroform and butanol fractions, significant changes were observed on the 5th day (P < 0.01) and 8th day (P < 0.001) after test substances administration. The reduction in blood glucose level with all test substances was observed to be more than that with the standard at the doses employed as shown in Table 3 .
Acute toxicity of ethanol extract of M. stenopetala leaves
The acute toxicity study of the ethanol extract of the leaves of the plant as shown in Table 4 suggests that there was no acute toxicity since there was no observed fatality. Therefore, the oral LD50 of ethanol extract of M. stenopetala (Baker f.) in mice was found to be greater than 50 g/kg.
DISCUSSION
Diabetes mellitus is known for many years as a serious complex chronic disorder which has been proved to be non-curable but controllable. This metabolic disorder is characterized by hyperglycemia and disturbances of carbohydrate, protein and fat metabolisms, secondary to an absolute or relative lack of the hormone insulin (Alberti and Zimmet, 1998) . Various types of modern drugs and plant medicines are known for their effectiveness in reducing the detrimental impacts that arise from the disease. Previous studies also confirmed the antihyperglycemic actions of different species of plants, such as Abrus precatorius L., Bridelia micrantha and Ocimum gratissimum L. (Deliorman et al., 2005; Sezik et al., 2005) . The hypoglycemic effects of the ethanol extract and its fractions observed in the present study are in agreement with that observed with the aqueous extract (Makonnen et al., 1997; Mussa et al., 2008) and its fractions (Mussa et al., 2008) . The more pronounced effect of ethanol crude extract than aqueous extract might be due to its good leaching capacity of the intracellular components of 2224. Pharm. Pharmacol. the plant material (leaves) which are inaccessible to water and has the potential to reduce blood sugar level. Chloroform and butanol fractions also caused almost similar significant reduction in blood glucose level at 180 and 240 min, But the chloroform fraction showed more significant effect at 120 min which might be attributed to the more solubility of the active component(s) in chloroform than butanol. The petroleum fraction and aqueous residue did not produce significant change in blood sugar level. This might be explained in terms of the less solubility of the active component(s) in these solvents.
Many studies showed that the dose of alloxan for inducing diabetes depend on the animal species, route of administration and nutritional status (Frode and Medeiros, 2008) . Based on the dose administered, syndromes similar to either type 1 or type 2 diabetes mellitus or glucose intolerance can be induced (Lenzen et al., 1996) .
The diabetogenic mechanism of alloxan is through generation of a redox cycle with the formation of superoxide radicals which undergo dismutation to hydrogen peroxide and accumulate in the cytosol simultaneously with calcium to cause rapid destruction of pancreatic β-cells (Szudelski, 2001) . The range of diabetogenic dose of alloxan is very narrow. In mice, the intravenous dose proposed to cause type 2 diabetes is in the range of 100 to 200 mg/kg (Machado et al., 2001; Miranda and Muriach, 2006) . The dose of alloxan employed to induce type 2 diabetes in this study was 120 mg/kg. Similar patterns of blood glucose reduction were observed with the extracts and most fractions in the diabetic mice as those in normoglycemic ones. Same explanation could be given for the differential potencies of the extracts and fractions. The chloroform and butanol fractions, however, exhibited similar reduction in glycemia like ethanol extract unlike the aqueous hypoglycemic effects. This might hint that both chloroform and butanol fractions might contain euglycemic active component(s). The duration of antihyperglycemic effect of the crude extracts and the fractions (chloroform and butanol) was extended until the end of the study. The fasting condition of the mice might also have contributed to this effect. The aqueous residue also showed antihyperglycemic effect which could be due to the presence of euglycemic active component(s).
Antihyperglycemic evaluation on repeated dose administration was performed only with both crude extracts (ethanol and aqueous extract) and fractions, such as chloroform and butanol. These test substances were chosen since they showed significant reduction in blood glucose level in both normoglycemic and diabetic mice with single doses. Ethanol extract resulted in more reduction in blood sugar level than the aqueous extract on the 3rd day while both extracts showed similar level of reduction on the 5 and 8th days. Chloroform and butanol fractions also reduced blood sugar level starting from the 5th day. From this study, it seems that the plant material contains more eugylcemic active components.
The observation that the ethanol extract did not show any toxic manifestations or lethality up to the dose level of 50 g/kg indicates the wide safety margin of the extract and supports the traditional use of the leaves of M. stenopetala for its food value.
Conclusion
Results of the present study showed that ethanol crude extracts and its chloroform and butanol fractions have both hypoglycemic and antihyperglycemic effects justifying the claimed traditional use of M. stenopetala for management of type 2 diabetes mellitus.
